公司资料
Sharps Technology 股价、新闻与催化剂
- 股票代码:
- STSS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.84 USD (+1.10%)
收盘价
最后更新: 2026年5月27日
77.9M USD
市值
股价为何变动
Current closing-price context is not available for STSS.
公司概览
业务概览
Sharps Technology is a medical device company focused on safer syringes and drug-delivery safety products. Its business is built around reducing contamination and improving handling in injectable workflows.
所在地与行业分类
Sharps Technology is headquartered in the United States and listed on NASDAQ. It sits in medical devices and drug-delivery hardware rather than biotechnology.
商业模式特征
The company depends on product adoption, regulatory progress, and the ability to scale its device platform into healthcare channels. Investors watch sales execution and manufacturing readiness.
生物医药行业定位
Sharps Technology is part of the medical-device safety layer of healthcare. It is not biotech, but it matters to the injection and drug-delivery ecosystem.
未来催化剂
- Sharps Technology’s catalysts are prefilled syringe and medication-delivery execution, plus any operating update that clarifies whether the company can keep scaling. The market will care about real commercial demand.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。